A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.

Dicanio M, Giaccherini M, Clay-Gilmour A, Macauda .... (2022). A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. Int J Cancer. https://doi.org/10.1002/ijc.34278

@article{paper36082445, title={ A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. }, author={ Dicanio M, Giaccherini M, Clay-Gilmour A, Macauda A, Sainz J, Machiela MJ, Rybicka-Ramos M, Norman AD, Tyczyńska A, Chanock SJ, Barington T, Kumar SK, Bhatti P, Cozen W, Brown EE, Suska A, Haastrup EK, Orlowski RZ, Dudziński M, Garcia-Sanz R, Kruszewski M, Martinez-Lopez J, Beider K, Iskierka-Jazdzewska E, Pelosini M, Berndt SI, Raźny M, Jamroziak K, Rajkumar SV, Jurczyszyn A, Vangsted AJ, Collado PG, Vogel U, Hofmann JN, Petrini M, Butrym A, Slager SL, Ziv E, Subocz E, Giles GG, Andersen NF, Mazur G, Watek M, Lesueur F, Hildebrandt MAT, Zawirska D, Ebbesen LH, Marques H, Gemignani F, Dumontet C, Várkonyi J, Buda G, Nagler A, Druzd-Sitek A, Wu X, Kadar K, Camp NJ, Grzasko N, Waller RG, Vachon C, Canzian F, Campa D. }, journal={ Int J Cancer }, year={ 2022 }, doi={ 10.1002/ijc.34278 }, pmid={ 36082445 } }